Winrho Sdf Lyophilisate For Solution For Injection 1500iu Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

WinRho SDF: Lyophilisate for solution for injection (1500IU)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

RhO [D] IMMUNE GLOBULIN (i MYOON GLOB yoo lin) is used to treat idiopathic thrombocytopenic purpura (ITP). This medicine is used in RhO negative mothers who are pregnant with a RhO positive child. It is also used after a transfusion of RhO positive blood into a RhO negative person.

In-Depth Information
Select a Medication

WinRho SDF 1500units Powder for Injection

NDC: 597300023
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Erythroblastosis Fetalis Prophylaxis, Idiopathic Thrombocytopenic Purpura (ITP), Rh Isoimmunization Prophylaxis

WinRho SDF 1500units Powder for Injection

Reported Side Effects for WinRho SDF 1500units Powder for Injection

Pale Skin Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Low Blood Pressure Incidence:
2.0%*
Severity: MODERATE
Onset: RAPID
Vomiting Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
6.0-30.6%*
Severity: MILD
Onset: EARLY
Chills Incidence:
8.0-34.7%*
Severity: MILD
Onset: RAPID
Headache Incidence:
11.0-11.2%*
Severity: MILD
Onset: EARLY
High Bilirubin Level Incidence:
21.4%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with WinRho SDF

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5